Workflow
AMD Gets A Downgrade And It's Not DeepSeek Related
AMDAMD(AMD) Benzinga·2025-01-28 21:06

Core Viewpoint - Melius Research analyst Ben Reitzes downgraded Advanced Micro Devices (AMD) from Buy to Hold and reduced the price target from 160to160 to 129, citing a need for a reevaluation after a significant stock increase earlier in 2024 [1] Group 1: Analyst Downgrade and Market Concerns - The downgrade reflects increased caution regarding AMD's long-term prospects in x86 servers and PCs, particularly due to competition from Nvidia's Arm-based CPUs [2] - Reitzes expressed concerns that custom and Nvidia CPUs may further cannibalize AMD's x86 server market, despite current success with AMD's Turin chip [2] Group 2: Revenue and Earnings Estimates - Reitzes adjusted revenue estimates downward for PC and server CPUs, leading to slightly lower operating margins, especially in the Data Center segment [3] - For 2024, AMD's EPS estimate remains at 3.33,withprojectedrevenuegrowthof133.33, with projected revenue growth of 13% year-over-year to 25.6 billion, including a 98% increase in Data Center revenue to 12.9billion[3]Thefourthquarter2024EPSisestimatedat12.9 billion [3] - The fourth-quarter 2024 EPS is estimated at 1.10, with revenue growth of 22% to 7.5billion,including7.5 billion, including 1.9 billion from AI GPU sales [4] Group 3: Future Earnings Projections - The 2025 EPS estimate has been reduced to 4.54,reflectinga194.54, reflecting a 19% revenue growth to 30.5 billion, with Data Center growth of 32% to 17billion[4]For2026,theEPSestimateisnow17 billion [4] - For 2026, the EPS estimate is now 5.75, with revenue growth of 17% to 35.5billion,includingDataCentergrowthof2435.5 billion, including Data Center growth of 24% to 21.1 billion [5] - The 2027 EPS estimate is adjusted to 6.1,withrevenuegrowthof126.1, with revenue growth of 12% to 39.9 billion, including Data Center growth of 18% to 24.9billion[6]Group4:CurrentStockPerformanceAMDstockiscurrentlydown0.7424.9 billion [6] Group 4: Current Stock Performance - AMD stock is currently down 0.74%, trading at 114.15 [7]